A quick peek into the report
Table of Contents
1.1 | Scope Of The Study |
1.2 | Research Methodology |
1.2.1 | Overall Market Estimation And Forecast |
1.2.2 | Bis Research Methodology |
1.3 | Report Description |
2.1 | EXECUTIVE SUMMARY |
3.1 | Cannabis Market Evolution And Trend |
3.2 | The Cannabis Ecosystem In North America: Estimate And Forecast |
3.3 | The Optimistic Estimate For The U.S. Mrijuana Market |
3.4 | Tax Revenue Estimation For The U.S. Marijuana Market |
4.1 | Introduction |
4.2 | Mergers And Acquisitions |
4.3 | Partnership, Collaboration & Joint Ventures |
4.4 | Product Launch |
4.5 | Business Expansion |
4.6 | Product Testing |
4.7 | Others |
5.1 | Introduction |
5.2 | Market Drivers |
5.2.1 | Automation Transforming The Cannabis Industry |
5.2.1.1 | Collaboration Of The Vending And Cannabis Industry |
5.2.1.2 | Automated Irrigation Systems And Fertigation |
5.2.2 | Increasing Adoption Of Information Technology In The Cannabis Industry |
5.2.3 | Rapid Adoption Of Cannabis For Medical Purposes |
5.2.4 | Multi-Faceted Applications Of Cannabis Derivatives |
5.2.5 | The Profitable Integration Of The Hydroponics And Cannabis Industry |
5.2.6 | The Combined Effect Of Vaper's Preference For Cannabis Oil And Increasing Adoption Of E-Cigarette |
5.3 | Market Challenges |
5.3.1 | Highly Volatile Regulatory Framework |
5.3.2 | Absence Of Market Leaders And Standards |
5.3.3 | The Issues Of Perception (Reputation Of Marijuana)/Marijuana Stigma |
5.3.4 | Federal Level Challenges |
5.3.4.1 | Lack Of Availability Of Bank Loans To Set Up Operations Due To Federal Banking Prerequisites |
5.3.4.2 | Federal Ban On Growing Industrial Hemp Forcing The Market Players To Import Raw Hemp |
5.3.5 | Highly Fragmented Supply Chain |
5.3.6 | Environmental Hazards |
6.1 | Porter’s Five Forces Analysis |
6.1.1 | Threat Of New Entrants |
6.1.1.1 | Entry Barriers (Government Policy And Capital Requirements) |
6.1.1.2 | Access To Distribution Channels |
6.1.1.3 | Economies Of Scale |
6.1.1.4 | Product Differentiation |
6.1.2 | Bargaining Power Of Buyers |
6.1.2.1 | Concentration Of Buyers |
6.1.2.2 | Importance Of Volume To Buyers |
6.1.2.3 | Threat Of Backward Integration |
6.1.2.4 | Buyer’s Information About Supplier’s Product |
6.1.2.5 | The Existence Of Black Market |
6.1.2.6 | Switching Cost |
6.1.2.7 | Legal And Regulatory Framework |
6.1.2.8 | Presence Of Substitutes |
6.1.3 | Bargaining Power Of Suppliers |
6.1.3.1 | Supplier Concentration |
6.1.3.2 | Threat Of Forward Integration |
6.1.3.3 | Product Differentiation |
6.1.3.4 | Switching Cost |
6.1.4 | Threat from substitutes |
6.1.4.1 | Buyer’s Propensity Towards Substitute |
6.1.4.2 | Consumer’s Switching Cost |
6.1.5 | Intensity Of Competitive Rivalry |
6.1.5.1 | Customer’s Loyalty Towards Brand |
6.1.5.2 | Intermittent Over Capacity |
6.1.5.3 | Product Differentiation |
6.1.5.4 | Industry Concentration |
6.1.5.5 | Entry Barriers |
6.1.5.6 | Exit Barriers |
6.2 | Value Chain Analysis |
6.2.1 | Introduction |
6.2.2 | Cannabis Growers/Producers |
6.2.3 | Pharmaceutical Companies |
6.2.3.1 | Research Facilities |
6.2.4 | Processing Industries |
6.2.5 | Packaging Industries |
6.2.6 | Dispensaries |
6.2.6.1 | Retail |
6.2.6.2 | Medical |
6.2.6.3 | Retail Outlets |
7.1 | Introduction |
7.2 | Regulatory Bodies |
7.2.1 | Health Canada- Marijuana For Medical Purposes Regulations (MMPR) |
7.2.2 | Council On Responsible Cannabis Regulation (CRCR) |
7.2.3 | National Organization For The Reform Of Marijuana Laws (NORML) |
7.3 | Legal Framework |
7.3.1 | Federal Marijuana Law- Controlled Substance Act (CSA) |
7.3.2 | Marijuana Control Act 2014 |
7.3.3 | Hemp Farming Act 2015 |
7.4 | Compliances |
7.4.1 | Massachusetts Marijuana Compliance |
7.4.2 | Marijuana Enforcement Tracking Reporting Compliance (METRC) |
7.5 | Consortiums |
7.5.1 | American Herbal Products Association (AHPA) |
7.5.2 | Association Of Responsible Cannabis Public Companies (ARCPC) |
7.5.3 | Hemp Industries Association (HIA) |
7.5.4 | Drug Policy Alliance |
7.5.5 | International Association For Cannabinoid Medicine (IACM) |
7.5.6 | National Cannabis Industry Association (NCIA) |
7.5.7 | Canadian Medical Cannabis Industry Association (CMCIA) |
7.5.8 | California Cannabis Industry Association (CCIA) |
7.5.9 | Illinois Cannabis Industry Association |
7.5.10 | North American Industrial Hemp Council Inc. (NAIHC) |
7.5.11 | Canadian Hemp Trade Alliance (CHTA) |
7.5.12 | Kentucky Hemp Industries Association(KYHIA) |
8.1 | Introduction |
8.1.1 | Market Statistics |
8.1.2 | Marijuana/Flowers |
8.1.2.1 | Market Statistics |
8.1.2.2 | Key Players |
8.1.3 | Industrial Hemp |
8.1.3.1 | Market Statistics |
8.1.3.2 | Key Players |
8.1.4 | Other Concentrates/Products |
8.1.4.1 | Kief |
8.1.4.2 | Hash |
8.1.4.3 | Hash Oil |
8.1.4.4 | Tinctures |
8.1.4.5 | Infusions |
9.1 | Introduction |
9.1.1 | Market Statistics |
9.2 | Applications Of Marijuana |
9.2.1 | Medicinal Applications |
9.2.1.1 | Market Statistics |
9.2.1.2 | Key Players |
9.2.2 | Recreational Application Of Marijuana |
9.2.2.1 | Market Statistics |
9.3 | Applications Of Industrial Hemp |
9.3.1 | Food And Baby Care |
9.3.1.1 | Market Statistics |
9.3.2 | Clothing & Textile |
9.3.2.1 | Market Statistics |
9.3.3 | Other Hemp Products |
9.3.3.1 | Market Statistics |
10.1 | Introduction |
10.1.1 | Market Statistics |
10.2 | The U.S. |
10.2.1 | Market Statistics |
10.2.2 | California |
10.2.3 | Colorado |
10.2.4 | Washington |
10.2.5 | Arizona |
10.2.6 | Michigan |
10.2.7 | Oregon |
10.2.8 | Others |
10.2.9 | Legal & Regulatory Framework |
10.2.9.1 | Marijuana |
10.2.9.2 | Industrial Hemp |
10.2.10 | Key Market Players |
10.3 | Canada |
10.3.1 | Market Statistics |
10.3.2 | Key Market Players |
11.1 | Growers |
11.1.1 | Canadian Cannabis Corporation |
11.1.1.1 | Company Overview |
11.1.1.2 | Financials |
11.1.1.2.1 | Overall Financials |
11.1.1.2.2 | Financial Summary |
11.1.1.3 | Key Developments |
11.1.2 | Plandai Biotechnology |
11.1.2.1 | Company Overview |
11.1.2.2 | Financials |
11.1.2.2.1 | Overall Financials |
11.1.2.2.2 | Financial Summary |
11.1.2.3 | Key Developments |
11.1.3 | Tweed Marijuana Inc. |
11.1.3.1 | Company Overview |
11.1.3.2 | Financials |
11.1.3.2.1 | Overall Financials |
11.1.3.2.2 | Financial Summary |
11.1.3.3 | Key Developments |
11.1.4 | Affinor Growers |
11.1.4.1 | Company Overview |
11.1.4.2 | Financials |
11.1.4.2.1 | Overall Financials |
11.1.4.2.2 | Financial Summary |
11.1.4.3 | Key Developments |
11.2 | Producers |
11.2.1 | Cannabis Sativa Inc. |
11.2.1.1 | Company Overview |
11.2.1.2 | Financials |
11.2.1.2.1 | Overall Financials |
11.2.1.2.2 | Financial Summary |
11.2.1.3 | Key Developments |
11.2.2 | Cannavest |
11.2.2.1 | Company Overview |
11.2.2.2 | Financials |
11.2.2.2.1 | Overall Financials |
11.2.2.2.2 | Financial Summary |
11.2.2.3 | Key Developments |
11.2.3 | Canna Brands Inc. |
11.2.3.1 | Company Overview |
11.2.3.2 | Financial Summary |
11.2.3.3 | Key Developments |
11.2.4 | Omnicanna Health Solutions |
11.2.4.1 | Company Overview |
11.2.4.2 | Financial Summary |
11.2.4.3 | Key Developments |
11.2.5 | Privateer Holdings, Inc. |
11.2.5.1 | Company Overview |
11.2.5.2 | Key Developments |
11.3 | Pharmaceutical & Research Companies |
11.3.1 | Arena Pharmaceuticals, Inc. |
11.3.1.1 | Company Overview |
11.3.1.2 | Financials |
11.3.1.2.1 | Overall Financials |
11.3.1.2.2 | Financial Summary |
11.3.1.3 | Key Developments |
11.3.2 | Cannabics Pharmaceuticals Inc. |
11.3.2.1 | Company Overview |
11.3.2.2 | Financial Summary |
11.3.2.3 | Key Developments |
11.3.3 | Cannabis Science, Inc. |
11.3.3.1 | Company Overview |
11.3.3.2 | Financials |
11.3.3.2.1 | Overall Financials |
11.3.3.2.2 | Financial Summary |
11.3.3.3 | Key Developments |
11.3.4 | GW Pharmaceuticals |
11.3.4.1 | Company Overview |
11.3.4.2 | Financials |
11.3.4.2.1 | Overall Financials |
11.3.4.2.2 | Revenue By Segment |
11.3.4.2.3 | Revenue By Region |
11.3.4.2.4 | Financial Summary |
11.3.4.3 | Key Developments |
11.3.5 | Hemp, Inc. |
11.3.5.1 | Company Overview |
11.3.5.2 | Financials |
11.3.5.2.1 | Overall Financials |
11.3.5.2.2 | Financial Summary |
11.3.5.3 | Key Developments |
11.3.6 | Insys Therapeutics |
11.3.6.1 | Company Overview |
11.3.6.2 | Financials |
11.3.6.2.1 | Overall Financials |
11.3.6.2.2 | Revenue By Segment |
11.3.6.2.3 | Financial Summary |
11.3.6.3 | Key Developments |
11.3.7 | Medical Marijuana Inc. |
11.3.7.1 | Company Overview |
11.3.7.2 | Financials |
11.3.7.2.1 | Overall Financials |
11.3.7.2.2 | Financial Summary |
11.3.7.3 | Key Developments |
11.3.8 | 22nd Century Group, Inc. |
11.3.8.1 | Company Overview |
11.3.8.2 | Financials |
11.3.8.2.1 | Overall Financials |
11.3.8.2.2 | Financial Summary |
11.3.8.3 | Key Developments |
11.3.9 | Otsuka Pharmaceutical Co. Ltd |
11.3.9.1 | Company Overview |
11.3.9.2 | Financials |
11.3.9.2.1 | Overall Financials |
11.3.9.2.2 | Revenue By Segment |
11.3.9.2.3 | Revenue By Region |
11.3.9.2.4 | Financial Summary |
11.3.9.3 | Key Developments |
11.3.10 | Sanofi Pharmaceuticals |
11.3.10.1 | Company Overview |
11.3.10.2 | Financials |
11.3.10.2.1 | Overall Financials |
11.3.10.2.2 | Financial Summary |
11.4 | Information Technology |
11.4.1 | Agrisoft Development Group |
11.4.1.1 | Company Overview |
11.4.1.2 | Key Developments |
11.4.2 | Endexx Corporation |
11.4.2.1 | Company Overview |
11.4.2.2 | Financials |
11.4.2.2.1 | Overall Financials |
11.4.2.3 | Key Developments |
11.4.3 | Green Technology Solutions Inc. (GTSO) |
11.4.3.1 | Company Overview |
11.4.3.2 | Financials |
11.4.3.2.1 | Overall Financials |
11.4.3.2.2 | Financial Summary |
11.4.3.3 | Key Developments |
11.4.4 | Quantum 9 |
11.4.4.1 | Company Overview |
11.4.4.2 | Financials |
11.4.4.3 | Key Developments |
11.5 | Equipment & Infrastructure |
11.5.1 | Advanced Cannabis Solutions |
11.5.1.1 | Company Overview |
11.5.1.2 | Financials |
11.5.1.2.1 | Overall Financials |
11.5.1.2.2 | Revenue By Segment |
11.5.1.2.3 | Financial Summary |
11.5.1.3 | Key Developments |
11.5.2 | Medbox, Inc. |
11.5.2.1 | Company Overview |
11.5.2.2 | Financials |
11.5.2.2.1 | Overall financials |
11.5.2.2.2 | Financial Summary |
11.5.2.3 | Key Developments |
11.5.3 | Surna, Inc. |
11.5.3.1 | Company Overview |
11.5.3.2 | Financials |
11.5.3.2.1 | Overall Financials |
11.5.3.2.2 | Financial Summary |
11.5.3.3 | Key Developments |
11.6 | Advisory Services And Education |
11.6.1 | Canna Grow Holdings |
11.6.1.1 | Company Overview |
11.6.1.2 | Financials |
11.6.1.2.1 | Overall Financials |
11.6.1.2.2 | Financial Summary |
11.6.1.3 | Key Developments |
11.7 | Others |
11.7.1 | Abattis Bioceuticals Corporation |
11.7.1.1 | Company Overview |
11.7.1.2 | Financials |
11.7.1.2.1 | Overall Financials |
11.7.1.2.2 | Financial Summary |
11.7.1.3 | Key Developments |
11.7.2 | Cannabis Therapy Corporation |
11.7.2.1 | Company Overview |
11.7.2.2 | Financials |
11.7.2.2.1 | Overall Financials |
11.7.2.2.2 | Financial Summary |
11.7.2.3 | Key Developments |
11.7.3 | Cannacare Docs |
11.7.3.1 | Company Overview |
11.8 | Application (APPS) Companies |
11.8.1 | Mass Roots |
11.8.1.1 | Company Overview |
11.8.2 | Eaze |
11.8.2.1 | Company Overview |
11.8.2.2 | Key Developments |
11.8.3 | Weedmaps |
11.8.3.1 | Company Overview |
11.8.4 | Meadow |
11.8.4.1 | Company Overview |
11.8.4.2 | Key Developments |
11.8.5 | Nestdrop |
11.8.5.1 | Company Overview |
11.8.5.2 | Key Developments |
11.8.6 | Leafly |
11.8.6.1 | Company Overview |
11.8.7 | Grassp |
11.8.7.1 | Company Overview |
11.8.8 | Dave |
11.8.8.1 | Company Overview |
11.8.9 | Frweed Pro |
11.8.9.1 | Company Overview |
TABLE 1 | TIMELINE OF MEDICAL MARIJUANA LEGALIZATION |
TABLE 2 | THE CANNABIS ECOSYSTEM IN NORTH AMERICA REVENUE SPLIT ($BILLION), 2015-2020 |
TABLE 3 | FULL LEGALIZATION OF MARIJUANA ACROSS THE U.S. AND ASSOCIATED TAX REVENUE ESTIMATE |
TABLE 4 | COMPARISON OF GROWING MARIJUANA IN SOIL-BASED AND SOIL-LESS MEDIUM |
TABLE 5 | CANNABIS SATIVA VS CANNABIS INDICA |
TABLE 6 | NORTH AMERICA CANNABIS DERIVATIVE MARKET VALUE ($MILLION), 2015-2020 |
TABLE 7 | NORTH AMERICA MARIJUANA MARKET VALUE($MILLION), BY APPLICATION, 2015-2020 |
TABLE 8 | NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020 |
TABLE 9 | NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 10 | NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020 |
TABLE 11 | NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY DISTRIBUTIONMODE, 2015-2020 |
TABLE 12 | NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($ MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 13 | NORTH AMERICA CANNABIS APPLICATION MARKET VALUE ($MILLION), 2015-2020 |
TABLE 14 | DISEASES & CURE BY CANNABIS |
TABLE 15 | INFORMATION ABOUT KEY MEDICINAL MARIJUANA DRUGS IN NORTH AMERICA |
TABLE 16 | NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020 |
TABLE 17 | NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 18 | NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 19 | NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 20 | NORTH AMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 21 | NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATION MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 22 | NORTH AMERICA CANNABIS MARKET BY REGION ($ MILLION), 2015-2020 |
TABLE 23 | THE U.S CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020 |
TABLE 24 | THE U.S. CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020 |
TABLE 25 | THE U.S. MARIJUANA MARKET VALUE ($MILLION), BY KEY STATES, 2015-2020 |
TABLE 26 | MARIJUANA LEGALIZATION DETAILS BY STATES |
TABLE 27 | MARIJUANA POSESSION DETAILS |
TABLE 28 | INDUSTRIAL HEMP POSESSION DETAILS |
TABLE 29 | CANADA CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020 |
TABLE 30 | CANADA CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020 |
FIGURE 1 | BIS RESEARCH METHODOLOGY |
FIGURE 2 | THE EUROPE E-LIQUID MARKET-RESEARCH METHODOLOGY |
FIGURE 3 | CANNABIS COMPARISON BY DERIVATIVE ($MILLION) 2015-2020 |
FIGURE 4 | CANNABIS COMPARISON BY APPLICATION ($ MILLION) 2014-2020 |
FIGURE 5 | CANNABIS COMPARISON BY GEOGRAPHY ($ MILLION) 2014-2020 |
FIGURE 6 | THE CANNABIS ECOSYSTEM WITH KEY PLAYERS |
FIGURE 7 | AN OPTIMISTIC ESTIMATE FOR U.S. MARIJUANA MARKET (2014) |
FIGURE 8 | KEY MERGERS & ACQUISITIONS (2013-15) |
FIGURE 9 | KEY PARTNERSHIPS & COLLABORATIONS (2013-15) |
FIGURE 10 | KEY PRODUCT LAUNCHES (2013-15) |
FIGURE 11 | KEY BUSINESS EXPANSION ACTIVITIES (2013-15) |
FIGURE 12 | KEY PRODUCT TESTING ACTIVITIES (2013-15) |
FIGURE 13 | OTHER KEY DEVELOPMENTS (2013-15) |
FIGURE 14 | BENEFITS OF USING CANNABIS VENDING MACHINES |
FIGURE 15 | WHY CANNABIS INDUSTRY NEEDS STANDARDS |
FIGURE 16 | NORTH AMERICA CANNABIS INDUSTRY ANALYSIS-PORTER’S FIVE FORCES |
FIGURE 17 | NORTH AMERICA CANNABIS MARKET VALUE CHAIN ANALYSIS |
FIGURE 18 | FEATURE OF MMPR |
FIGURE 19 | MISSION OF CRCR |
FIGURE 20 | MISSION OF NORML |
FIGURE 21 | PROPOSED BEST PRACTICES FOR REGULATION OF CANNABIS GROWING BY AHPA |
FIGURE 22 | ARCPC MISSION |
FIGURE 23 | HIA MISSION |
FIGURE 24 | DPA MISSION |
FIGURE 25 | STEPS TAKEN BY IACM IN THE CANNABIS INDUSTRY |
FIGURE 26 | KEY FEATURES OF NCIA |
FIGURE 27 | CMCIA MISSION |
FIGURE 28 | NAIHC MISSION |
FIGURE 29 | KEY VARIETIES OF CANNABIS STRAINS |
FIGURE 30 | THE PSYCHOACTIVE EFFECTS OF MARIJUANA |
FIGURE 31 | MEDICAL BENEFITS OF MARIJUANA |
FIGURE 32 | INDUSTRIES BENEFITING FROM INDUSTRIAL HEMP |
FIGURE 33 | APPLICATIONS OF CANNABIS PLANT |
FIGURE 34 | NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 35 | NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 36 | APPLICATIONS OF INDUSTRIAL HEMP |
FIGURE 37 | NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 38 | NORTHAMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 39 | NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATIONS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 40 | LEGALIZATION STATUS OF CANNABIS |
FIGURE 41 | CANADIAN CANNABIS CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION) |
FIGURE 42 | PLANDAI BIOTECH OVERALL FINANCIALS, 2012-15 ($ MILLION) |
FIGURE 43 | TWEED MARIJUANA OVERALL FINANCIALS, 2013-15 ($ MILLION) |
FIGURE 44 | AFFINOR GROWERS OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 45 | CANNABIS SATIVA OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 46 | CANNAVEST OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 47 | ARENA PHARMACEUTICALS OVERALL FINANCIALS, 2012-14 ($MILLION) |
FIGURE 48 | CANNABIS SCIENCE, INC. OVERALL FINANCIALS, 2012-14 ($MILLION) |
FIGURE 49 | GW PHARMACEUTICALS; OVERALL FINANCIALS 2012-14 ($MILLION) |
FIGURE 50 | REVENUE BY SEGMENT 2012-14 |
FIGURE 51 | REVENUE BY REGION2012-2014 |
FIGURE 52 | HEMP INC. OVERALL FINANCIALS, 2012-15 ($ MILLION) |
FIGURE 53 | INSYS THERAPEUTICS OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 54 | MEDICAL MARIJUANA INC. OVERALL FINANCIALS, 2012-14 ($MILLION) |
FIGURE 55 | 22ND CENTURY GROUP OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 56 | OTSUKA OVERALL FINANCIALS, 2012-2014 ($ MILLION) |
FIGURE 57 | SANOFIPHARMA OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 58 | ENDEXX CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION) |
FIGURE 59 | GREEN TECHNOLOGY SOLUTIONS; OVERALL FINANCIALS, 2012-2015 ($ MILLION) |
FIGURE 60 | ADVANCED CANNABIS SOLUTIONS OVERALL FINANCIALS, 2013-2014 ($ MILLION) |
FIGURE 61 | MEDBOX OVERALL FINANCIALS, 2012-2014 ($ MILLION) |
FIGURE 62 | SURNA INC. OVERALL FINANCIALS, 2012-2014 ($MILLION) |
FIGURE 63 | CANNAGROW OVERALL FINANCIALS, 2012-14 ($MILLION) |
FIGURE 64 | ABATTIS BIOCEUTICALS OVERALL FINANCIALS 2013-14 ($MILLION) |
FIGURE 65 | CANNABIS THERAPY CORP. OVERALL FINANCIALS, 2014-15 ($MILLION) |
Report Description
Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp.
The size of the market for cannabis implies that market participants are more varied. Thus, the company profile section has been broken down into different types of market participants: producers, information technology, funding & finance, equipment & infrastructure, research & development, advisory services & education, branding, sales & marketing, and retail & dispensary.
Scope of the Research Study
The following pointers will encompass the scope of the research study and will lend a better understanding to the reader.
• The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp
• The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized
• Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014)
• The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state’s revenue are clubbed as others
• Through the forecast period, the ‘other’ states segment will also include the revenue from further states that are anticipated to legalize medical marijuana
• The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity
• The report includes the estimates of different entities of the cannabis ecosystem
• The report also includes the optimistic revenue estimate for the benchmark year only for the U.S
• Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included
Market Overview
Cannabis is the most widely used of all psychoactive drugs in the market due to its derivative products and their uses, its applications and wide acceptance. Owing to the medicinal and industrial uses of the cannabis plant, cannabis market is growing rapidly. Factors like multi-faceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others.
The U.S. state California generates the maximum revenue $1.15 billion in the marijuana market among all the states in the U.S. while Oregon and Rhode Island will be growing at the fastest CAGR of 36.10% and 36.93% respectively. If the industry keeps on growing with the same pace, it will spread to all the 50 states of the U.S.
Table of Contents
North America Cannabis Market
Focus on Application, Derivative, and Region – Estimation & Forecast, 2015-2020